Antioxidant treatment in chronic liver diseases;Antioxidáns kezelés krónikus májbetegségekben

Orvosi Hetilap

Volumn 147, Issue 24, 2006, Pages 1113-1118

  Lengyel, Gabriella ^a,b   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Gasztroenterológiai és Endokrinológiai Kutató Csoport ^*  (Hungary)

Author keywords

Antioxidant treatment; Chronic liver disease; Free radicals; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; FREE RADICAL; METADOXINE; PLACEBO; S ADENOSYLMETHIONINE; SILYMARIN;

ALCOHOL LIVER DISEASE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DISEASE COURSE; HUMAN; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG EFFECT; FATTY LIVER; LIVER DISEASE; METABOLISM; VIRUS HEPATITIS;

ANTIOXIDANTS; CHRONIC DISEASE; DISEASE PROGRESSION; FATTY LIVER; FREE RADICALS; HEPATITIS, ALCOHOLIC; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER DISEASES; OXIDATIVE STRESS;

EID: 33748120353     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Aboutwerat, A., Pemberton, R, Smith, A. és mtsai: Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim. Biophys. Acta, 2003, 1637, 142-150.
2. Adams, L. A., Zein, C., Angulo, P. és mtsai: A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am. J. Gastrocnterol., 2004, 99, 2365-2368.
3. Aleynik, S. I., Leo, M., Ma, X. és mtsai: Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J. Hepatol., 1997, 27, 554-561.
4. Arteel, G. E.: Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology, 2003, 124, 778-790.
5. Beckman, J. S.: Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol., 1996, 9, 836-844.
6. Blázovics A.: Az alkoholos májkárosodás biokémiája. Folia Hepatológica, 4, Suppl., 1999, 9-18.
7. Caballeria, J., Pares, A., Bru, C. és mtsai: Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver J. Hepatol., 1998, 28, 54-60.
8. Carnovale, C. E., Scapini, C., Alvarez, M. és mtsai: Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver.J. Hepatol., 2000, 32, 798-804.
9. Clemens, M. G.: Nitric oxide in liver injury. Hepatology, 1999, 30, 1-5.
10. Cortez-Pinto, H., Carneiro de Moura, M., Day, C. P. és mtsai: Non-alcoholic steatohepatitis: From cell biology to clinical practice. J. Hepatol., 2006, 44, 197-208.
11. D'Angio, C. T., Finkelstein, J.: Oxygen regulation of gene expression: a study in opposites. Mol. Genet. Metab., 2000, 71, 371-380.
12. Fehér J., Blázovics A., Lengyel G.: Ubikinon és más gyökfogók hatása oxidatív stressz okozta károsodásokban. Orv. Hetil., 2002, 143, 1027-1031.
13. Fehér, J., Csomós, G., Vereckei A.: - Free radicals in Biology and Medicine. Springer Verlag, Berlin- Heidelberg-New York-London-Paris-Tokyo, 1987.
14. Fehéer J., Lengyel G.: A nem alkoholos steatohepatitis pathogenezise és klinikuma. Eur. J. Gastroent. Hepat. (magyar kiadás), 2002, VI, 185-191.
15. Fehér J., Lengyel G., Blázovics A.: Antioxidáns kezelés jelentosége a mindennapi gyakorlatban. Háziorvosi Továbbképzo Szemie, 2004, 9, 487-491.
16. Fehér, J., Lengyel, G.: A New Approach to Drug Therapy in Non-alcoholic Steatoliepatitis (NASH). J. International Med. Res., 2003, 31, 537-551.
17. Fehér, J., Lengyel, G., Blázovics, A.: Oxidative Stress in the Liver and Biliary Tract Diseases. Scand. J. Gastroenterol., 1998, 33 (Suppl. 228.), 38-46.
18. Ferenci, P., Dragosics, B., Dittrich, H. és mtsai: Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J. Hepatol., 1989, 9, 105-113.
19. Floreani, A., Baragiotta, A., Martines, D. és mtsai: Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment. Pharmacol. Ther., 2000, 14, 353-358.
20. Fortenberry, J. D., Owens, M., Brown, L.: S-nitrosoglutathione enhances neutrophil DNA fragmentation and cell death. Am. J. Physiol., 1999, 276, 435-442.
21. Fridovich, J.: Biological effects of the superoxide radical. Arch. Biochem. Biophys., 1986, 247, 1-11.
22. Fridovich, I.: Superoxide radical and superoxide dismutases. Ann. Rev. Biochem., 1995, 64, 97-112.
23. Garcia-Ruiz, C., Morales, A., Colell, A. és mtsai: Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology, 1995, 21, 207-214.
24. Hagymási, K., Blátovics, A., Lengyel G.: Oxidative damage in alcoholic liver disease. Eur. J. Gastroent. Hepat., 2000, 12, 49-54.
25. Hagymási K., Blázovics A., Lengyel G. és mtsai: A máj redox homeostasisának tanulmányozása kísérletes és humán vizsgálatokban. Acta Pharmaceutika Hungarica, 2004, 74, 51-63.
26. Hagymási K., Fehér J. (kordinátor) és a multicentrikus munkacsoport: A sylimarin hatása és tolerálhatósága idült májbetegségekben. Medicus Universalis, 2000, XXXIII, 179-182.
27. Hasegwa, T., Yoneda, M., Nakamura, K. és mtsai: Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study Aliment. Pharmacol. Ther., 2001, 15, 1667-1672.
28. Hill, D. B., Devalaraja, R., Joshi-Barve, S. és mtsai: Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kuppfer cells, in vitro. Clin. Biochem., 1999, 32, 563-570.
29. Kim, Y. M., Kim, T., Chung, H. és mtsai: Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology, 2000, 32, 770-778.
30. Kiyici, M., Gulten, M., Gurel, S. és mtsai: Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can. J. Gastroenterol., 2003, 17, 713-718.
31. Kono, H., Bradford, B., Yin, M. és mtsai: CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol., 1999, 277, 1259-1267.
32. Lengyel G., Fehér J.: Az alkohol okozta májkárosodás. Gyógyszerészet, 2004, 48, 67-72.
33. Li, J., Billiar, T.: Nitric oxide. IV: determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol., 1999, 276, 1069-1073.
34. Lindor, K. D., Kowdley, K., Heathcote, E. és mtsai: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of randomized trial. Hepatology, 2004, 39, 770-778.
35. Lieber, C. S., Weiss, D., Groszmann, R. és mtsai: II Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol. Clin. Exp. Res., 2003, 27, 1765-1772.
36. Look, M. P., Gerard, A., Rao, G. és mtsai: Interferon/ antioxidant combination therapy for chronic hepatitis C: a controlled pilot trial. Antiviral. Res., 1999, 43, 113-122.
37. Mahmood, S., Yamada, G., Niiyama, G. és mtsai: Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. Free. Radic. Res., 2003, 37, 781-785.
38. Mahmood, S., Kawanaka, M., Kamei, A. és mtsai: Immunhistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid. Redox. Signal., 2004, 6, 19-24.
39. Majano, P. L., Garcia-Monzon, C., Lopez-Cabrera, M. és mtsai: Inducible nitric oxide synthase expression in chronic viral hepatitis: evidence for a virus-induced gene upregulation. J. Clin. Invest., 1998, 101, 1343-1352.
40. Majano, P., Lara-Pezzi, E., Lopez-Cabrera, M. és mtsai: Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappa B-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation. Hepatology, 2001, 34, 1218-1224.
41. Mato, J. M., Alvarez, L., Ortiz, P. és mtsai: S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther., 1997, 73, 265-280.
42. Mato, J. M., Cámara, J., Fernandez-de-Paz, J. és mtsai: S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebocontrolled, double-blind, multicenter clinical trial. J. Hepatol., 1999, 30, 1081-1089.
43. McKim, S. E., Gabele, E., Isayama, F. és mtsai: Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology, 2003, 125, 1834-1844.
44. Medina, J., Moreno-Otero, R.: Pathophysiological Basis for Antioxidant Therapy in Chronic Liver Disease. Drugs, 2005, 65, 2445-2461.
45. Mezey, E., Potter, J., Rennie-Tankersley, L. és mtsai: A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J. Hepatol., 2004, 40, 40-46.
46. Miglio, F., Rovati, L. C., Santaro, A. és mtsai: Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parael-group, placebo-controlled prospective clinical study. Arzneimittelforschung, 2000, 50, 722-727.
47. Moncade, S., Palmer, R., Higgs, E.: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
48. Németh E., Fehér J., Nagy V. és mtsai: Antioxidánsok szerepe a prevencióban. Orv. Hetil, in press.
49. Okuda, M., Li, K., Beard, M. és mtsai: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 2002, 122, 366-375.
50. Otani, K., Korenaga, M., Beard, M. és mtsai: Hepatitis C virus core protein, cytochrome P4502E1 and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology, 2005, 128, 96-107.
51. Pár A.: A kezelés lehetoségei alkoholos májbetegségekben (Absztinencia, táplálkozás, gyógyszerek, májtranszplantáció) Orv. Hetil., 2000, 141, 827-833.
52. Sen, C. K.: Cellular thiols and redox-regulated signal transcluction. Curr. Top. Cell. Regul., 2000, 36, 1-30.
53. Serviddio, G., Pereda, J., Pallardo, F. és mtsai: Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology, 2004, 39, 711-720.
54. Suzuki, Y. J., Forman, H., Sevanian, A.: Oxidants as stimulators of signal transduction. Free. Radic. Biol. Med., 1997, 22, 269-285.
55. Xiong, S., She, H., Sung, C. és mtsai: Iron-dependent activation of NF-kappa B in Kuppfer cells: a priming mechanism for alcoholic liver disease. Alcohol, 2003, 30, 107-113.
56. Yin, M., Gabele, E., Wheeler, M. és mtsai: Alcohol-induced free radicals in mice: Direct toxicants or signaling molecules? Hepatology, 2001, 34, 935-942.
57. Yin, M., Wheeler, M., Kono, H. és mtsai: Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology, 1999, 117, 942-952.
58. Váli L., Blázovics A., Fehér J.: A metadoxin terápiás hatásának összehasonlítása alkoholos és nem alkoholos zsírmájban. Orv. Hetil., 2005, 146, 2409-2414.